Baker McKenzie advises CSL on its strategic collaboration with VarmX
CSL has received advice from Baker McKenzie regarding its strategic partnership with privately held Dutch biotech company VarmX BV to support the development of VMX-C001 and the signing of a contract with VarmX shareholders that gives CSL the sole right to purchase all issued and outstanding shares of the business.